The case of litigation/arbitration is a repurchase dispute over pledged securities with a principal of 630 million yuan. The institution for filing/accepting arbitration is the Fujian Higher Peoples Court.
In the afternoon of July 23rd, the companys vice chairman, deputy general manager, and one of the actual controllers, Zhang Minghao, had three supplementary Pledged Shares, with a total of 73 million 362 thousand and 400 shares, which accounted for 42.15% of the share of its shares.
According to the announcement, Zhang Huahao pledged 16,686.24 million shares to Societe Generale Securities, accounting for 95.87% of his shares, accounting for 17.14% of the companys total equity.
In July 23rd, the Shenzhen Stock Exchange issued a notice that it had restricted sale of shares held by the Changsheng biological giant shareholder and Dong Jiangao. This also means that even if the longevity creature has fallen through the line, it can not be leveled.
In July 24th, Xingye securities issued a announcement to respond to the market concerns: the initial transactions of two major shareholders, Yu Chen pan and Zhang Minghao, were 45 million yuan and 630 million yuan respectively. The number of pledge shares were 11 million shares and 167 million shares respectively, and the performance guarantee ratio was 277% and 307% respectively. Yu Chen pan and Zhang Minghao jointly pledge 178 million biological longevity creatures, and the amount to be bought back is 675 million yuan.
Will the longevity creature be forced to withdraw from the market? Gao Junfang son: the delisting is delisting.
As for the impact of the vaccine event on the company, Gao Junfangs son and vice president of life, Zhang Minghao, responded exclusively to the financial help of the new Beijing newspaper: (the serious consequences of the company) have gone, and what? The delisting. He said the company is now in a state of discontinuation.